# Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

> **NCT05789589** · PHASE1,PHASE2 · RECRUITING · sponsor: **Baptist Health South Florida** · enrollment: 46 (estimated)

## Conditions studied

- Cancer
- Metastasis
- Metastatic Cancer
- Brain Metastases
- Brain Metastases, Adult

## Interventions

- **DRUG:** Azeliragon
- **RADIATION:** Stereotactic radiosurgery
- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT05789589
- **Lead sponsor:** Baptist Health South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-17
- **Primary completion:** 2027-03-16
- **Final completion:** 2027-08
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789589, "Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05789589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*